News

The patent provides protection for co-delivery technology that is used in the company’s ImuXen product range. The patent covers a method which deals with packaging a protein vaccine

So far, Alliance has acquired the rights to more than 50 pharmaceutical products. The company distributes its products through wholesalers, retail pharmacies, hospitals and an international network of

Zelboraf is indicated as a treatment for patients with unresectable or metastatic melanoma with BRAFV600E mutation. Biologics will administer the Patient Partners program, a clinical support service through

The JV, registered in Kuwait as Avita Medical Mena (AVM), will be 70% controlled by Avita Medical. AVM will be responsible for sales and marketing efforts in the

Sirolimus is currently being evaluated in a Phase III study entitled ‘study assessing double-masked uveitis treatment’ (Sakura) to evaluate the safety and efficacy of different doses of sirolimus.

The company expects to recruit around 1,200 patients with severe TBI (Glasgow Coma Scale scores of 4-8), who have sustained a closed-head trauma in SyNAPSe trial. The results

Thionyl chloride is an intermediate used by industrial customers to manufacture agrochemicals, dyestuffs, fine chemicals and pharmaceuticals. The company expects to complete the expansion in the second half

The new JV – Aurospharma – intends to construct a plant to manufacture non penicillin and non cephalosporin Rx generics and other drugs that are categorized as over

The grant of $600,000 is expected to support the research to characterize the role of the phosphoinositide 3-kinase (PI3K) in preclinical models of skin autoimmune inflammation. Dynavax vice